These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18280694)

  • 21. New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies.
    Sundriyal S; Viswanad B; Ramarao P; Chakraborti AK; Bharatam PV
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4959-62. PubMed ID: 18752947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluation.
    Parmenon C; Guillard J; Caignard DH; Hennuyer N; Staels B; Audinot-Bouchez V; Boutin JA; Dacquet C; Ktorza A; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1617-22. PubMed ID: 18255290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling.
    Deng G; Liu Z; Ye F; Luo X; Zhu W; Shen X; Liu H; Jiang H
    Eur J Med Chem; 2008 Dec; 43(12):2699-716. PubMed ID: 18329752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic homoserine lactone-derived sulfonylureas as inhibitors of Vibrio fischeri quorum sensing regulator.
    Frezza M; Soulère L; Reverchon S; Guiliani N; Jerez C; Queneau Y; Doutheau A
    Bioorg Med Chem; 2008 Apr; 16(7):3550-6. PubMed ID: 18294853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C; Alam MS; Hamid H; Javed K; Shafi S; Ali Y; Alam P; Pasha MA; Dhulap A; Bano S; Nazreen S; Haider S
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5298-303. PubMed ID: 25442322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.
    Ibrahim MK; Eissa IH; Alesawy MS; Metwaly AM; Radwan MM; ElSohly MA
    Bioorg Med Chem; 2017 Sep; 25(17):4723-4744. PubMed ID: 28720328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
    Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
    Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational screening of phthalate monoesters for binding to PPARgamma.
    Kaya T; Mohr SC; Waxman DJ; Vajda S
    Chem Res Toxicol; 2006 Aug; 19(8):999-1009. PubMed ID: 16918238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents.
    Yamamoto K; Itoh T; Abe D; Shimizu M; Kanda T; Koyama T; Nishikawa M; Tamai T; Ooizumi H; Yamada S
    Bioorg Med Chem Lett; 2005 Feb; 15(3):517-22. PubMed ID: 15664804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) gamma by organotin compounds.
    Hiromori Y; Nishikawa J; Yoshida I; Nagase H; Nakanishi T
    Chem Biol Interact; 2009 Jul; 180(2):238-44. PubMed ID: 19497422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARgamma agonists.
    Blanc-Delmas E; Lebegue N; Wallez V; Leclerc V; Yous S; Carato P; Farce A; Bennejean C; Renard P; Caignard DH; Audinot-Bouchez V; Chomarat P; Boutin J; Hennuyer N; Louche K; Carmona MC; Staels B; Pénicaud L; Casteilla L; Lonchampt M; Dacquet C; Chavatte P; Berthelot P; Lesieur D
    Bioorg Med Chem; 2006 Nov; 14(22):7377-91. PubMed ID: 16887353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 36. Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.
    Weyer R; Hitzel V
    Arzneimittelforschung; 1988 Aug; 38(8):1079-80. PubMed ID: 3196400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.
    Little PJ; Ballinger ML; Survase S; Osman N; Ogru E; Geytenbeek S; Bruemmer D; Nigro J
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):274-9. PubMed ID: 18356692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARγ Agonistic Activity of Sulphonylureas.
    Banerjee D; Bharaj HS; Banerjee M
    Endocr Metab Immune Disord Drug Targets; 2019; 19(4):467-471. PubMed ID: 30605064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR analysis of PPAR-gamma agonists as anti-diabetic agents.
    Dixit A; Saxena AK
    Eur J Med Chem; 2008 Jan; 43(1):73-80. PubMed ID: 17482722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.